MedTrace Logo

PREdiCtIon of Weanability, Survival and Functional outcomEs After ECLS

NCT05444764 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 800

Last updated 2024-01-05

No results posted yet for this study

Summary

Extracorporeal life support (ECLS) is used as a last resort intervention in patients with severe cardiac, circulatory and/or respiratory failure with high (\>80%) expected mortality. Despite considerable improvements in patient selection and outcomes, mortality and morbidity after ECLS remain high. An improved selection and management of patients who are supported with ECLS is therefore unquestionably needed from a perspective of optimal patient care and the socio-economic impact of this costly intervention.

Conditions

  • Extracorporeal Membrane Oxygenation
  • Extracorporeal Membrane Oxygenation Complication

Sponsors & Collaborators

  • Leiden University Medical Center

    collaborator OTHER

  • Erasmus Medical Center

    collaborator OTHER

  • St. Antonius Hospital

    collaborator OTHER

  • Catharina Ziekenhuis Eindhoven

    collaborator OTHER

  • Isala

    collaborator OTHER

  • UMC Utrecht

    lead OTHER

Principal Investigators

  • Dirk W Donker, Professor · UMC Utrecht

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-16
Primary Completion
2024-03-01
Completion
2024-03-01

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05444764 on ClinicalTrials.gov